Order of the President of the General Court of 23 May 2016 —
Pari Pharma v EMA
(Case T‑235/15 R)
Application for interim measures — Access to documents — Regulation (EC) No 1049/2001 — Documents held by the EMA concerning information submitted by an undertaking as part of its application for authorisation to place a medicinal product on the market — Order granting suspension of operation of the decision to grant a third party access to the documents — Application for cancellation — No change in circumstances — Article 159 of the Rules of Procedure of the General Court
Application for interim measures — Suspension of operation of a measure — Interim measures — Modification or setting aside — Condition — Change in circumstances — Concept (Rules of Procedure of the General Court, Art. 159) (see paras 27, 28)
Re:
| APPLICATION based on Article 159 of the Rules of Procedure of the General Court seeking cancellation of the order of 1 September 2015 in Pari Pharma v EMA (T‑235/15 R, EU:T:2015:587), by which it granted the suspension of operation of Decision EMA/271043/2015 of the EMA of 24 April 2015, granting to a third party, pursuant to Regulation (EC) No 1049/2001 of the European Parliament and of the Council of 30 May 2001 regarding public access to European Parliament, Council and Commission documents (OJ 2001 L 145, p. 43), access to certain documents containing information submitted in the context of an application for marketing authorisation for the medicinal product Vantobra. |
Operative part
1. | | The application for cancellation of the order of 1 September 2015 in Pari Pharma v EMA (T‑235/15 R, EU:T:2015:587) is dismissed. |